The presence of these antibodies, beyond being a random association because of their high frequency in other autoimmune diseases, in anti-MDA5 DM/CADM patients has been related to RP-ILD and vasculopathic lesions. Here, IFIH1 is linked to clinically amyopathic dermatomyositis.